Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World Population

Hypoglycemia and acute metabolic complications (AMCs; ketoacidosis, hyperosmolarity, and coma) are glycemic outcomes that have high cost and high morbidity; these outcomes must be taken into consideration when choosing initial second-line therapy after metformin. We conducted a retrospective cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallia, Amisha, O’Brien, Matthew J., Liss, David T., Kang, Raymond H., Cooper, Andrew J., Gilmer, Amy, Ackermann, Ronald T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240148/
https://www.ncbi.nlm.nih.gov/pubmed/34195559
http://dx.doi.org/10.1016/j.mayocpiqo.2021.02.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240148/
https://www.ncbi.nlm.nih.gov/pubmed/34195559
http://dx.doi.org/10.1016/j.mayocpiqo.2021.02.008

Ejemplares similares